Building on nearly four years of evidence gathering by the Study, the ACCISS team has created an online toolkit to provide national and international health policymakers and others with a better understanding of the underlying parameters that define universal access (and the lack thereof) to insulin for people living with type 1 and 2 diabetes in low- and middle-income countries (LMICs). They provide evidence and practical guidance related to access to insulin in LMICs, and give recommendations for stakeholders interested in improving access to insulin.
Visit the toolkit at http://accisstoolkit.haiweb.org/
Access a Major Obstacle for One in Two People Using Insulin to Manage Type 2 Diabetes – An ACCISS Study paper published in The Lancet Diabetes and Endocrinology estimates that, between 2018 and 2030, the number of people with type 2 diabetes using insulin will rise to 79 million. But without improved availability and affordability, over half of those will face challenges in accessing this life-saving medicine. Read our press release.
ACCISS Multi-Stakeholder Meeting – The Multi-stakeholder Meeting was held in Amsterdam on 11 September. It allowed stakeholders from a variety of perspectives to come together to discuss the barriers of global access to insulin and ways to move past these barriers. To read more about the event or watch selected recordings from the day, click here.